Eye, ear, nose, and throat diseases

Anesthesia and Uncommon Diseases

Volumn , Issue , 2006, Pages 1-27

  McGoldrick, Kathryn E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141602212-1.50004-4     Document Type: Chapter

References (147)

1. McGoldrick KE Ocular pathology and systemic diseases: Anesthetic implications. Anesthesia for Ophthalmic and Otolaryngologic Surgery 1992, 210-226. WB Saunders, Philadelphia. K.E. McGoldrick (Ed.).
2. Lee PP, Feldman ZW, Ostermann J, et al. Longitudinal prevalence of major eye diseases. Arch Ophthalmol 2003, 121:1303-1310.
3. DiGeorge AM, Harley RD The association of aniridia, Wilms' tumor, and genital abnormalities. Arch Ophthalmol 1966, 75:796-798.
4. Petersen RA, Walton DS Optic nerve hypoplasia with good visual acuity and visual field defects: A study of children of diabetic mothers. Arch Ophthalmol 1977, 95:254-258.
5. Skarf B, Hoyt CS Optic nerve hypoplasia in children: Association with anomalies of the endocrine and central nervous systems. Arch Ophthalmol 1984, 102:62-67.
6. Costin G, Murphree AL Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child 1985, 139:249-254.
7. Newlin AC, Sugar J Corneal and external eye manifestations of systemic disease. Ophthalmology 2004, 527-534. Mosby, St. Louis. 2nd ed. M. Yanoff, J.S. Duker (Eds.).
8. Yorston D A perspective from a surgeon practicing in the developing world. Surv Ophthalmol 2000, 45:51-52.
9. Muñoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation study. Arch Ophthalmol 2000, 118:819-825.
10. Solomon R, Donnenfeld ED Recent advances and future frontiers in treating age-related cataracts. JAMA 2003, 290:248-251.
11. Jick SS, Vasilakis-Scaramozza C, Maier WC The risk of cataract among users of inhaled steroids. Epidemiology 2001, 12:229-234.
12. Cumming RG, Mitchell P, Leeder SR Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997, 337:8-14.
13. Garbe E, Suissa S, LeLorier J Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998, 280:539-543.
14. Cumming RG, Mitchell P Alcohol, smoking, and cataracts: The Blue Mountain Eye Study. Arch Ophthalmol 1997, 115:1296-1303.
15. Richards W, Donnell GN, Wilson WA, et al. The oculocerebrorenal syndrome of Lowe. Am J Dis Child 1965, 109:185-203.
16. Morris RC Renal tubular acidosis: Mechanisms, classification, and implications. N Engl J Med 1969, 281:1405.
17. Cotlier E Congenital varicella cataract. Am J Ophthalmol 1978, 86:627-629.
18. Pyeritz RE The Marfan syndrome. Ann Rev Med 2000, 51:481-510.
19. Steward DJ Manual of Pediatric Anesthesia 1979, 246-247. Churchill Livingstone, New York.
20. Roizen MF Hyperthyroidism. Essence of Anesthesia Practice 2002, 186. WB Saunders, Philadelphia. 2nd ed. M.F. Roizen, L.A. Fleisher (Eds.).
21. Greer MA Antithyroid drugs in the treatment of thyrotoxicosis. Thyroid Today 1980, 3:1-18.
22. Williams LT, Lefkowitz RJ, Watanabe AM, et al. Thyroid hormone regulation of beta-adrenergic number. J Biol Chem 1977, 252:2787-2789.
23. Zonszein J, Santangelo RP, Mackin JF, et al. Propranolol therapy in thyrotoxicosis: A review of 84 patients undergoing surgery. Am J Med 1979, 66:411-416.
24. Roizen MF Anesthetic implications of concurrent diseases. Anesthesia 2000, 927-930. Churchill Livingstone, New York. 4th ed. R.D. Miller (Ed.).
25. Kaplan JA, Cooperman LH Alarming reactions to ketamine in patients taking thyroid medication treated with propranolol. Anesthesiology 1971, 35:229-230.
26. Jervis GA Phenylpyruvic oligophrenia (phenylketonuria). Res Publ Assoc Res Nerv Ment Dis 1954, 33:259.
27. Wyngaarden JB Homocystinuria. Cecil Textbook of Medicine 1979, 2028. WB Saunders, Philadelphia. 15th ed. P.B. Beeson, W. McDermott, J.B. Wyngaarden (Eds.).
28. Brown BR, Walson PD, Taussig LM Congenital metabolic diseases in pediatric patients: Anesthetic implications. Anesthesiology 1975, 43:197.
29. McDonald L, Bray C, Love F, et al. Homocystinuria, thrombosis, and the blood platelets. Lancet 1964, 1:745.
30. Holmgren G, Falkmer S, Hambraeus L Plasma insulin content and glucose tolerance in homocystinuria. Ups J Med Sci 1975, 78:215.
31. McGoldrick KE Anesthetic management of homocystinuria. Anesthesiol Rev 1981, 8:42-45.
32. Dean J, Schechter A Sickle cell anemia: Molecular and cellular basis of therapeutic approaches. N Engl J Med 1978, 299:752.
33. Djaiani GN, Cheng DC, Carroll JA, et al. Fast track cardiac anesthesia in patients with sickle cell abnormalities. Anesth Analg 1999, 89:598-603.
34. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995, 333:206-213.
35. McDade WA Sickle cell disease. Essence of Anesthesia Practice 2002, 302. WB Saunders, Philadelphia. 2nd ed. M.F. Roizen, L.A. Fleisher (Eds.).
36. Skolruk PR, Pomerantz RJ, de la Monte SM, et al. Dual infection of the retina with human immunodeficiency virus type I and cytomegalovirus. Am J Ophthalmol 1989, 107:361.
37. Knight PR Immune suppression. Essence of Anesthesia Practice 2002, 193. WB Saunders, Philadelphia. 2nd ed. M.F. Roizen, L.A. Fleisher (Eds.).
38. Terry TL Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: Preliminary report. Am J Ophthalmol 1942, 25:203.
39. Silverman W Retrolental Fibroplasia: A Modern Parable 1980, Grune & Stratton, New York.
40. 2 levels and retrolental fibroplasia: A report of the Cooperative Study. Pediatrics 1977, 60:655.
41. Merritt JC, Sprague DH, Merritt WE Retrolental fibroplasia: A multifactorial disease. Anesth Analg 1981, 60:109.
42. Lucey JF, Dangman B A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984, 73:82.
43. Flynn JT Acute proliferative retrolental fibroplasia: Multivariate risk analysis. Trans Am Ophthalmol Soc 1983, 81:549.
44. Steward DJ Preterm infants are more prone to complications following minor surgery than are term infants. Anesthesiology 1982, 56:304-306.
45. Tetzlaff JE, Annand DW, Pudimat MA, et al. Postoperative apnea in a full-term infant. Anesthesiology 1988, 69:426-428.
46. Liu LMP, Coté CJ, Goudsouzian NG, et al. Life-threatening apnea in infants recovering from anesthesia. Anesthesiology 1983, 59:506-510.
47. Kurth CD, Spitzer AR, Broennle AM, et al. Postoperative apnea in preterm infants. Anesthesiology 1987, 66:483-488.
48. Welborn LG, Hannallah RS, Luban NLC, et al. Anemia and postoperative apnea in former preterm infants. Anesthesiology 1991, 74:1003-1006.
49. Jobe AH, Bancalari E Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
50. Giacoia GP, Venkataraman PS, West-Wilson KI, Faulkneer MJ Follow-up of school-age children with bronchopulmonary dysplasia. J Pediatr 1997, 130:400-408.
51. Groothuis JR, Gutierrez KM, Lauer BA Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988, 82:199-203.
52. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: Results from the trial of indomethacin prophylaxis in preterms. JAMA 2003, 289:1124-1129.
53. Schreiber MD, Gin-Mestan K, Marks JD, et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003, 349:2099-2107.
54. Martin RJ Nitric oxide for preemies Not so fast (editorial). N Engl J Med 2003, 349:2157-2159.
55. Schiff D, Stern L, Leduc J Chemical thermogenesis in newborn infants: Catecholamine excretion and the plasma nonesterified fatty acid response to cold exposure. Pediatrics 1966, 37:577-582.
56. Bucher H-U, Fanconi S, Baeckert P, et al. Hyperoxemia in newborn infants: Detection by pulse oximetry. Pediatrics 1989, 84:226-230.
57. Shah SN, Gibbs S, Upton CJ, et al. Incontinentia pigmenti associated with cerebral palsy and cerebral leukomalacia: A case report and literature review. Pediatr Dermatol 2003, 20:491-494.
58. Hubert JN, Callen JP Incontinentia pigmenti presenting as seizures. Pediatr Dermatol 2002, 19:550-552.
59. Cates CA, Dandekar SS, Flanagan DW, Moore AT Retinopathy of incontinentia pigmenti: A case report with thirteen years follow-up. Ophthalmic Genet 2003, 24:247-252.
60. Goldberg MF Macular vasculopathy and its evolution in incontinentia pigmenti. Trans Am Ophthalmol Soc 1998, 96:55-65.
61. Goldberg MF, Custis PH Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology 1993, 100:1645-1654.
62. Chen SD, Hanson R, Hundal K Foveal hypoplasia and other ocular signs: A possible case of incontinentia pigmenti?. Arch Ophthalmol 2003, 121:921.
63. Savovets D Ketamine: An effective general anesthetic for use in electroretinography. Ann Ophthalmol 1978, 10:1510.
64. Tanskanen P, Kylma T, Kommonen B, Karhunen U Propofol influences the electroretinogram to a lesser degree than thiopentone. Acta Anaesthesiol Scand 1996, 40:480-485.
65. Yanase J, Ogawa H Effects of halothane and sevoflurane on the electroretinogram of dogs. Am J Vet Res 1997, 58:904-909.
66. Chaudhary V, Hansen R, Lindgren H, Fulton A Effects of telazol and nembutal on retinal responses. Doc Ophthalmol 2003, 107:45-51.
67. Banoub M, Tetzlaff JE, Schubert A Pharmacologic and physiologic influences affecting sensory evoked potentials. Anesthesiology 2003, 99:716-737.
68. Chi OZ, Field C Effects of isoflurane on visual evoked potentials in humans. Anesthesiology 1986, 65:328-330.
69. Uhl RR, Squires KC, Bruce DL, Starr A Effect of halothane anesthesia on the human cortical visual evoked response. Anesthesiology 1980, 53:273-276.
70. Chi OZ, Ryterbrand S, Field C Visual evoked potentials during thiopentone-fentanyl-nitrous oxide anaesthesia in humans. Can J Anaesth 1989, 36:637-640.
71. Chi OZ, Subramoni J, Jasaitis D Visual evoked potentials during etomidate administration in humans. Can J Anaesth 1990, 37:452-456.
72. Hou WY, Lee WY, Lin SM, et al. The effects of ketamine, propofol and nitrous oxide on visual evoked potentials during fentanyl anesthesia. Ma Tsui Hsueh Tsa Chi Anaesthesiol Sin 1993, 31:97-102.
73. Raudzens PA Intraoperative monitoring of evoked potentials. Ann NY Acad Sci 1982, 388:308-326.
74. Chi OZ, McCoy CL, Field C Effects of fentanyl anesthesia on visual evoked potentials in humans. Anesthesiology 1987, 67:827-830.
75. McGoldrick KE The open globe: Is an alternative to succinylcholine necessary? (editorial). J Clin Anesth 1993, 5:1-4.
76. Mahajan RP, Grover VK, Sharma SL, et al. Lidocaine pretreatment in modifying IOP increases. Can J Anaesth 1987, 34:41.
77. Sweeney J, Underhill S, Dowd T, Mostafa SM Modification by fentanyl and alfentanil of the intraocular pressure response to suxamethonium and tracheal intubation. Br J Anaesth 1989, 63:688-691.
78. Ghignone M, Noe S, Calvillo O, et al. Effects of clonidine on IOP and perioperative hemodynamics. Anesthesiology 1988, 68:707.
79. Miller RD, Way Wl, Hickey RF Inhibition of succinylcholine-induced increased intraocular pressure by nondepolarizing muscle relaxants. Anesthesiology 1968, 29:123-126.
80. Meyers EF, Krupin T, Johnson M, et al. Failure of nondepolarizing neuromuscular blockers to inhibit succinylcholine-induced increased intraocular pressure a controlled study. Anesthesiology 1978, 48:149-151.
81. Vachon CA, Warner DO, Bacon DR Succinylcholine and the open globe: Tracing the teaching. Anesthesiology 2003, 99:220-223.
82. Ginsberg B, Glass PS, Quill T, et al. Onset and duration of neuromuscular blockade following high-dose vecuronium administration. Anesthesiology 1989, 71:201-205.
83. Schwarz S, Ilias W, Lackner F, et al. Rapid tracheal intubation with vecuronium: The priming principle. Anesthesiology 1985, 62:388-391.
84. Libonati MM, Leahy JJ, Ellison N Use of succinylcholine in open eye injury. Anesthesiology 1985, 62:637-640.
85. Donlon JV Succinylcholine and open eye injury: II. Anesthesiology 1986, 64:525-526.
86. Ostermeier AM, Roizen MF, Hautkappe M, et al. Three sudden postoperative arrests associated with epidural opioids in patients with sleep apnea. Anesth Analg 1997, 85:452-460.
87. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
88. Piccirillo JF More information needed about the long-term health consequences of mild to moderate obstructive sleep apnea (editorial). Arch Otolaryngol Head Neck Surg 2001, 127:1400-1401.
89. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
90. Nymann P, Backer V, Dirksen A, Lange P Increased diastolic blood pressure associated with obstructive sleep apnea independently of overweight (abstract). Sleep 2000, 23:A61.
91. Bixler EO, Vgontzas AN, Lucas T, et al. The association between sleep-disordered breathing and cardiovascular abnormalities (abstract). Sleep 2000, 23:A59.
92. Benumof JL Obstructive sleep apnea in the adult obese patient: Implications for airway management. J Clin Anesth 2001, 13:144-156.
93. Hudgel DW Mechanisms of obstructive sleep apnea. Chest 1992, 101:541-549.
94. Kuna ST, Sant'Ambrogio G Pathophysiology of upper airway closure during sleep. JAMA 1991, 266:1384-1389.
95. Beydon L, Hassapopoulos J, Quera MA, et al. Risk factors for oxygen desaturation during sleep after abdominal surgery. Br J Anaesth 1992, 69:137-142.
96. Boudewyns AN, DeBacker WA, Van de Heyning PH Pattern of upper airway obstruction during sleep before and after uvulopalatopharyngoplasty in patients with obstructive sleep apnea. Sleep Med 2001, 2:309-315.
97. Catalfumo FJ, Golz A, Westerman ST, et al. The epiglottis and obstructive sleep apnoea syndrome. J Laryngol Otol 1998, 112:940-943.
98. Farmer WC, Giudici SC Site of airway collapse in obstructive sleep apnea after uvulopalatopharyngoplasty. Ann Otol Rhinol Laryngol 2000, 109:581-584.
99. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002, 346:404-412.
100. Gottlieb DJ Cardiac pacing a novel therapy for sleep apnea? (editorial). N Engl J Med 2002, 346:444-445.
101. Pirsig W, Verse T Long-term results in the treatment of obstructive sleep apnea. Eur Arch Otorhinolaryngol 2000, 257:570-577.
102. Itasaka Y, Miyazaki S, Tanaka T, et al. Uvulopalatopharyngoplasty for obstructive sleep-related breathing disorders: One-year follow-up. Psychiatry Clin Neurosci 2001, 55:261-264.
103. Vilaseca I, Morello A, Montserrat JM, et al. Usefulness of uvulopalatopharyngoplasty with genioglossus and hyoid advancement in the treatment of obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 2002, 128:435-440.
104. Finkelstein Y, Stein G, Ophir D, et al. Laser-assisted uvulopalatoplasty for the management of obstructive sleep apnea: Myths and facts. Otolaryngol Head Neck Surg 2002, 128:429-434.
105. American Sleep Apnea Association Sleep apnea and same day surgery 1999, American Sleep Apnea Association, Washington, DC. http://www.sleepapnea.org/sameday/html.
106. Morgan AH, Zitsch RP Recurrent respiratory papillomatosis in children: A retrospective study of management and complications. Ear Nose Throat J 1986, 65:19-28.
107. Mounts P, Shah KV, Kashima H Viral etiology of juvenile and adult onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A 1982, 79:5425-5429.
108. Derkay CS Task force on recurrent respiratory papillomas. Arch Otolaryngol Head Neck Surg 1995, 121:1386-1391.
109. Rimell FL, Shoemaker DL, Pou AM, et al. Pediatric respiratory papillomatosis: Prognostic role of viral subtyping and cofactors. Laryngoscope 1997, 107:915-918.
110. Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latest infections. Obstet Gynecol 1999, 93:475-479.
111. Leventhal BG, Kashima HK, Mounts P, et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. N Engl J Med 1991, 325:613.
112. McGlennen RC, Adams GL, Lewis CM, et al. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis. Head Neck 1993, 15:504-512.
113. Shikowitz MJ, Abramson AL, Freeman K, et al. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: Immediate and long-term results. Laryngoscope 1998, 108:962-967.
114. Myer CM, Wiliging P, Cotton R Use of a laryngeal microresector system. Laryngoscope 1999, 109:1165-1166.
115. Orr RJ, Elwood T Special challenging problems in the difficult pediatric airway: Lymphangioma, laryngeal papillomatosis, and subglottic hemangioma. Anesthesiol Clin North Am 1998, 16:869-883.
116. Derkay CS Recurrent respiratory papillomatosis. Laryngoscope 2001, 111:57-69.
117. Benjamin B, Lines V Endoscopy and anesthesia in non-infective airway obstruction in children. Anaesthesia 1972, 27:22-29.
118. Kennedy MG, Chinyanga HM, Steward DJ Anaesthetic experience using a standard technique for laryngeal surgery in infants and children. Can Anaesth Soc J 1981, 28:561.
119. Armstrong LR, Derkay CS, Reeves WC Initial results from the National Registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 1999, 125:743-748.
120. Cohen SR, Thompson JW Lymphangiomas of the larynx in infants and children: A survey of pediatric lymphangioma. Ann Otol Rhinol Laryngol 1986, 127:1.
121. Schulman SR, Jones BR, Slotnick N, et al. Fetal tracheal intubation with intact uteroplacental circulation. Anesth Analg 1993, 76:197.
122. Tanaka M, Sato S, Naito H, et al. Anaesthetic management of a neonate with prenatally diagnosed cervical tumor and upper airway obstruction. Can J Anaesth 1994, 41:236.
123. Ogita S, Tsuto T, Nakamura K, et al. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994, 29:784.
124. Popa ER, Tervaert JW The relation between Staphylococcus aureus and Wegener's granulomatosis: Current knowledge and future directions. Intern Med 2003, 43:771-780.
125. Watters K, Russell J Subglottic stenosis in Wegener's granulomatosis and the nitinol stent. Laryngoscope 2003, 113:2222-2224.
126. Wardyn KA, Yeinska K, Matuszkiewicz-Rowinska J, Chipczynska M Pseudotumour orbitae as the initial manifestation in Wegener's granulomatosis in a 7-year-old girl. Clin Rheumatol 2003, 22:472-474.
127. Biswas J, Babu K, Gopal L, et al. Ocular manifestations of Wegener's granulomatosis: Analysis of nine cases. Indian J Ophthalmol 2003, 51:217-223.
128. Straatsma BR Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol 1957, 44:789.
129. Nolle B, Specks U, Luderman J, et al. Anticytoplasmatic autoantibodies: Their immuno-diagnostic value in Wegener's granulomatosis. Ann Intern Med 1989, 11:28-40.
130. Langford CA, Sneller MC, Hallahan CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 1996, 39:1754-1760.
131. Levy A, Hall L, Yeudall WA, Lightman SL p53 gene mutation in pituitary adenomas: Rare events. Clin Endocrinol 1994, 41:809-814.
132. Faglia G, Ambrosi B Hypothalamic and pituitary tumors: General principles. Clinical Endocrinology 1992, 113-122. Blackwell, Oxford. A. Grossman (Ed.).
133. Burrow GN, Wortzman G, Rewcastle NB, et al. Microadenomas of the pituitary and abnormal sellar tomograms in unselected autopsy series. N Engl J Med 1981, 304:156-158.
134. Lamberts SW, Hofland LJ, de Herder WW, et al. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol 1993, 14:27-55.
135. Burn JM Airway difficulties associated with anaesthesia in acromegaly. Br J Anaesth 1972, 44:413-414.
136. Schmitt H, Buchfelder M, Radespiel-Troger M, Fahlbusch R Difficult intubation in acromegalic patients: Incidence and predictability. Anesthesiology 2000, 93:110-114.
137. Murrant NJ, Garland DJ Respiratory problems in acromegaly. J Laryngol Otol 1990, 104:52-55.
138. Smith M, Hirsch NP Pituitary disease and anaesthesia. Br J Anaesth 2000, 85:3-14.
139. Quinn FB Ludwig angina (commentary). Arch Otolaryngol Head Neck Surg 1999, 125:599.
140. Marple BF Ludwig angina: A review of current airway management. Arch Otolaryngol Head Neck Surg 1999, 125:596-598.
141. Tschiassny K Ludwig's angina: An anatomic study of the lower molar teeth in its pathogenesis. Arch Otolaryngol Head Neck Surg 1943, 38:485-496.
142. Penner J: Ludwig's angina. In Roizen MF, Fleisher LA (eds): Essence of Anesthesia Practice, 2nd ed. Philadelphia 2002, p 210.
143. Thomas TT Ludwig's angina. Ann Surg 1908, 47:161. 335.
144. Taffel M, Harvey SC Ludwig's angina: An analysis of 45 cases. Surgery 1942, 11:841-850.
145. Patterson HC, Kelly JH, Strome M Ludwig's angina: An update. Laryngoscope 1982, 92:370-378.
146. Kurien M, Mathew J, Job A, Zachariah N Ludwig's angina. Clin Otolaryngol 1997, 22:263-265.
147. Loughnan TE, Allen DE Ludwig's angina: The anesthetic management of nine cases. Anaesthesia 1985, 40:295.